Iams WT[au] - Search Results

Year	Number of Results
2014	2
2015	5
2016	1
2017	4
2018	7
2019	6
2020	4
2021	2
2022	3

1

Immunotherapeutic approaches for small-cell lung cancer.

Iams WT, Porter J, Horn L. Iams WT, et al. Nat Rev Clin Oncol. 2020 May;17(5):300-312. doi: 10.1038/s41571-019-0316-z. Epub 2020 Feb 13. Nat Rev Clin Oncol. 2020. PMID: 32055013 Free PMC article. Review.

2

Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice.

Le X, Sakai H, Felip E, Veillon R, Garassino MC, Raskin J, Cortot AB, Viteri S, Mazieres J, Smit EF, Thomas M, Iams WT, Cho BC, Kim HR, Yang JC, Chen YM, Patel JD, Bestvina CM, Park K, Griesinger F, Johnson M, Gottfried M, Britschgi C, Heymach J, Sikoglu E, Berghoff K, Schumacher KM, Bruns R, Otto G, Paik PK. Le X, et al. Among authors: iams wt. Clin Cancer Res. 2022 Mar 15;28(6):1117-1126. doi: 10.1158/1078-0432.CCR-21-2733. Clin Cancer Res. 2022. PMID: 34789481 Clinical Trial.

3

Novel Targeted Therapies for Metastatic Melanoma.

Iams WT, Sosman JA, Chandra S. Iams WT, et al. Cancer J. 2017 Jan-Feb;23(1):54-58. doi: 10.1097/PPO.0000000000000242. Cancer J. 2017. PMID: 28114255 Review.

4

Neoadjuvant Treatment for Locally Invasive Esophageal Cancer.

Iams WT, Villaflor VM. Iams WT, et al. World J Surg. 2017 Jul;41(7):1719-1725. doi: 10.1007/s00268-017-3959-x. World J Surg. 2017. PMID: 28271259 Review.

5

Front Line Applications and Future Directions of Immunotherapy in Small-Cell Lung Cancer.

Wong SK, Iams WT. Wong SK, et al. Among authors: iams wt. Cancers (Basel). 2021 Jan 29;13(3):506. doi: 10.3390/cancers13030506. Cancers (Basel). 2021. PMID: 33572705 Free PMC article. Review.

6

Major milestones in translational oncology.

Dragani TA, Castells A, Kulasingam V, Diamandis EP, Earl H, Iams WT, Lovly CM, Sedelaar JP, Schalken JA. Dragani TA, et al. Among authors: iams wt. BMC Med. 2016 Jul 28;14(1):110. doi: 10.1186/s12916-016-0654-y. BMC Med. 2016. PMID: 27469586 Free PMC article.

7

Anaplastic Lymphoma Kinase as a Therapeutic Target in Non-Small Cell Lung Cancer.

Iams WT, Lovly CM. Iams WT, et al. Cancer J. 2015 Sep-Oct;21(5):378-82. doi: 10.1097/PPO.0000000000000142. Cancer J. 2015. PMID: 26389762 Free PMC article. Review.

8

COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors.

Chen YW, Tucker MD, Beckermann KE, Iams WT, Rini BI, Johnson DB. Chen YW, et al. Among authors: iams wt. Eur J Cancer. 2021 Sep;155:291-293. doi: 10.1016/j.ejca.2021.07.017. Epub 2021 Jul 28. Eur J Cancer. 2021. PMID: 34400057 Free PMC article. No abstract available.

9

Stop fRETting the Target: Next-Generation RET Inhibitors Have Arrived.

Iams WT, Lovly CM. Iams WT, et al. Cancer Discov. 2018 Jul;8(7):797-799. doi: 10.1158/2159-8290.CD-18-0489. Cancer Discov. 2018. PMID: 29967074 Free PMC article.

10

Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade.

Iams WT, Lovly CM. Iams WT, et al. Clin Cancer Res. 2015 Oct 1;21(19):4270-7. doi: 10.1158/1078-0432.CCR-14-2518. Clin Cancer Res. 2015. PMID: 26429980 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results